ZAMPLIFIN Trademark

Trademark Overview


On Tuesday, April 4, 2023, a trademark application was filed for ZAMPLIFIN with the United States Patent and Trademark Office. The USPTO has given the ZAMPLIFIN trademark a serial number of 97872179. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2024. This trademark is owned by Shionogi & Co., Ltd.. The ZAMPLIFIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDs, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammationn and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, thrombocytopenia, disease and disorders of the liver, and opioid-induced constipation; pharmaceutical preparations for treating allergic rhinitis
zamplifin

General Information


Serial Number97872179
Word MarkZAMPLIFIN
Filing DateTuesday, April 4, 2023
Status700 - REGISTERED
Status DateTuesday, September 10, 2024
Registration Number7498646
Registration DateTuesday, September 10, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDs, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammationn and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, thrombocytopenia, disease and disorders of the liver, and opioid-induced constipation; pharmaceutical preparations for treating allergic rhinitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShionogi & Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP

Party NameShionogi & Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP

Party NameShionogi & Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP

Trademark Events


Event DateEvent Description
Friday, April 7, 2023NEW APPLICATION ENTERED
Friday, April 14, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, April 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 7, 2023ASSIGNED TO EXAMINER
Monday, July 10, 2023LETTER OF SUSPENSION E-MAILED
Monday, July 10, 2023SUSPENSION LETTER WRITTEN
Monday, July 10, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 8, 2024SUSPENSION INQUIRY WRITTEN
Monday, January 8, 2024INQUIRY TO SUSPENSION E-MAILED
Monday, January 8, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, January 29, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 4, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 17, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 5, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 25, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 25, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED